Work with your hormone signals.
Enclomiphene blocks estrogen feedback at certain receptors, increasing LH and FSH signals that can stimulate the testes to produce testosterone.
Enclomiphene is an oral selective estrogen receptor modulator (SERM). It has been studied in certain men with secondary hypogonadism to stimulate their own testosterone production. It is not FDA-approved, and treatment is not appropriate for everyone.
Men’s hormone-health intake, a live clinician evaluation, medication if prescribed and care-team messaging. Your clinician determines the dose, quantity and monitoring plan. Laboratory testing is paid separately. Shipping is included if prescribed.
Discuss your medical history, medicines and fertility goals with your clinician. Possible risks include headache, visual changes, changes in mood and hormone levels, and blood clots. Seek urgent medical care for sudden vision changes, chest pain, trouble breathing or a swollen painful leg. Long-term safety and symptom benefits have not been established. Compounded medications are not FDA-approved.
Choose $149 monthly or $399 every three months. Both plans renew automatically until canceled. Laboratory testing is paid separately. Treatment requires clinician approval and pharmacy availability in your state. Your prescription quantity and dispensing schedule are determined by your clinician; payment does not guarantee a prescription.
Or $399 every 3 months · Renews until canceled
Men’s hormone-health intake · Live clinician evaluationUnderstand your levels and explore your options. Enclomiphene works through your body’s hormone signals to stimulate testosterone production in certain men. Your clinician decides whether it fits your health history and goals.
Enclomiphene is not FDA-approved. A clinician determines suitability, testing and treatment. Availability varies by state and pharmacy.
Product image is an illustrative packaging concept. Actual packaging may differ. Compounded medications are not reviewed by the FDA for safety, effectiveness or quality before marketing.
Enclomiphene blocks estrogen feedback at certain receptors, increasing LH and FSH signals that can stimulate the testes to produce testosterone.
Studies focused on men with secondary hypogonadism. Symptoms alone cannot establish the cause of low testosterone or tell you whether this treatment is appropriate.
Research found testosterone and sperm-count changes in selected men. That does not guarantee fertility, symptom relief or long-term safety. Follow-up matters.
Sources: Randomized studies in secondary hypogonadism and FDA review of enclomiphene citrate. Study results do not establish that a compounded preparation is equivalent to the investigational product. Illustrations are conceptual.
Enclomiphene and testosterone work differently. Your clinician helps determine which options are appropriate.
| Treatment approach | Enclomiphene | Testosterone therapy |
|---|---|---|
| How it works | Stimulates hormone signals involved in your own testosterone production | Provides testosterone directly |
| Typical format | Oral capsule | Injection, gel or other prescribed formulation |
| Fertility considerations | Sperm counts were maintained in selected clinical studies; fertility is not guaranteed | Can suppress sperm production; discuss fertility plans first |
| FDA status | Enclomiphene is not FDA-approved | Some testosterone products are FDA-approved; compounded preparations are not |
| Evaluation and monitoring | Required | Required |
| Who decides | Your licensed clinician | Your licensed clinician |
This is a comparison of treatment approaches, not a claim that one is safer or more effective. Endocrine Society guidance.
Complete your men’s hormone-health intake, including symptoms, medications, health history and fertility goals.
Meet with a licensed clinician. Complete the evaluation and blood work they require before a treatment decision.
If prescribed and available in your state, your medication ships from the dispensing pharmacy. Follow your individual instructions.
Stay connected about symptoms and side effects. Your clinician guides follow-up blood work and treatment changes.
Swipe to explore the four steps
Verified FutureSelf enclomiphene reviews are not yet available. Patient stories will appear here when shared with permission. Individual results vary.
No. Enclomiphene is a SERM that acts on hormone feedback signals. Testosterone therapy provides testosterone directly. They have different risks and are not interchangeable.
A licensed clinician determines eligibility after reviewing your symptoms, medical history, hormone levels and goals. Research has focused on selected men with secondary hypogonadism. It is not a treatment for every cause of low testosterone.
Your clinician determines the testing needed to assess hormone levels and safety before treatment and during follow-up. Complete all requested testing before starting or changing medication.
Clinical studies found maintained sperm concentrations in selected men, but enclomiphene does not guarantee fertility or pregnancy. Tell your clinician about fertility goals; a specialist evaluation may be appropriate.
No. Enclomiphene is not FDA-approved. Compounded products are not reviewed by the FDA for safety, effectiveness or quality before marketing. Discuss the evidence, risks and alternatives with your clinician.
Choose $149 monthly or $399 every three months ($133 per month equivalent). Both plans renew automatically until canceled. Labs are paid separately. Prescription quantity and dispensing are clinician-directed. Manage your plan in your patient portal or contact support@futureselfrx.ai.
This offer is currently unavailable in Alabama, Arkansas, California, Florida, Kentucky, South Carolina and Washington, D.C. Availability is checked at checkout and remains subject to clinician and pharmacy approval.
Timing and response vary. Changes in blood test results do not guarantee symptom improvement. Your clinician assesses both your results and how you feel during follow-up.
Potential risks include headache, visual changes, changes in mood or hormone levels and blood clots. Long-term safety has not been established. Seek prompt medical advice for new symptoms and urgent care for sudden vision changes, chest pain, breathing difficulty or a swollen painful leg.